Related references
Note: Only part of the references are listed.Multiple effects of IL-21 on human NK cells in ex vivo expansion
Qi Li et al.
IMMUNOBIOLOGY (2015)
CD155 (PVR/Necl5) Mediates a Costimulatory Signal in CD4+ T Cells and Regulates Allergic Inflammation
Yumi Yamashita-Kanemaru et al.
JOURNAL OF IMMUNOLOGY (2015)
NK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors
Olga M. Anton et al.
JOURNAL OF IMMUNOLOGY (2015)
Coordinated Expression of DNAM-1 and LFA-1 in Educated NK Cells
Monika Enqvist et al.
JOURNAL OF IMMUNOLOGY (2015)
Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease
Gero Lueg et al.
NEUROBIOLOGY OF AGING (2015)
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
L. Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Fingolimod treatment promotes regulatory phenotype and function of B cells
Berit Gruetzke et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins
Lucas Ferrari de Andrade et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells
Tilman Schneider-Hohendorf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J. Chan et al.
NATURE IMMUNOLOGY (2014)
Effects of Blood Transportation on Human Peripheral Mononuclear Cell Yield, Phenotype and Function: Implications for Immune Cell Biobanking
Anita Posevitz-Fejfar et al.
PLOS ONE (2014)
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
Elaine Kingwell et al.
BMC NEUROLOGY (2013)
CD226 Gly307Ser association with multiple autoimmune diseases: A meta-analysis
Zhi-Xin Qiu et al.
HUMAN IMMUNOLOGY (2013)
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation
Isabell Hamann et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
Ralf Gold et al.
LANCET (2013)
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis
Heinz Wiendl et al.
NATURE REVIEWS NEUROLOGY (2013)
Natural killer cells in human autoimmune disorders
Leslie A. Fogel et al.
ARTHRITIS RESEARCH & THERAPY (2013)
The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-Activating Ligand PVR
Giulia Matusali et al.
JOURNAL OF VIROLOGY (2012)
Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
Natasja Nielsen et al.
PLOS ONE (2012)
Complementary Phosphorylation Sites in the Adaptor Protein SLP-76 Promote Synergistic Activation of Natural Killer Cells
Hun Sik Kim et al.
SCIENCE SIGNALING (2012)
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis
Justin S. A. Perry et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction
Michele Ardolino et al.
BLOOD (2011)
Cutting Edge: NKG2D-Dependent Cytotoxicity Is Controlled by Ligand Distribution in the Target Cell Membrane
Emily Martinez et al.
JOURNAL OF IMMUNOLOGY (2011)
Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients
Trina A. Johnson et al.
JOURNAL OF IMMUNOLOGY (2011)
Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
Wenzheng Jiang et al.
JOURNAL OF IMMUNOLOGY (2011)
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
Mario Skarica et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy
Simone C. Wuest et al.
NATURE MEDICINE (2011)
Intrathecal effects of daclizumab treatment of multiple sclerosis
B. Bielekova et al.
NEUROLOGY (2011)
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
M. C. Kowarik et al.
NEUROLOGY (2011)
Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy
J. E. Martinez-Rodriguez et al.
CLINICAL IMMUNOLOGY (2010)
Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection
Marina Cella et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
Norman Putzki et al.
EUROPEAN NEUROLOGY (2010)
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis
A. Alcina et al.
GENES AND IMMUNITY (2010)
Synergistic Signals for Natural Cytotoxicity Are Required to Overcome Inhibition by c-Cbl Ubiquitin Ligase
Hun Sik Kim et al.
IMMUNITY (2010)
An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells
Jayne F. Martin et al.
JOURNAL OF IMMUNOLOGY (2010)
Tethering of Intercellular Adhesion Molecule on Target Cells Is Required for LFA-1-Dependent NK Cell Adhesion and Granule Polarization
Catharina C. Gross et al.
JOURNAL OF IMMUNOLOGY (2010)
Role of the innate immune system in the pathogenesis of multiple sclerosis
Roopali Gandhi et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. (vol 9, pg 381, 2010)
D. Wynn et al.
LANCET NEUROLOGY (2010)
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
Daniel Wynn et al.
LANCET NEUROLOGY (2010)
Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
Bibiana Bielekova et al.
ARCHIVES OF NEUROLOGY (2009)
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells
Cristina Cerboni et al.
BLOOD (2009)
Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate
K. L. Sand et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Natural killer cells in human autoimmunity
Malin Flodstrom-Tullberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
CD226 Gly307Ser association with multiple autoimmune diseases
J. P. Hafler et al.
GENES AND IMMUNITY (2009)
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Nicholas D. Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
Mattias Carlsten et al.
JOURNAL OF IMMUNOLOGY (2009)
Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+Foxp3 expression in subjects with multiple sclerosis
Arthur A. Vandenbark et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Regulatory NK-Cell Functions in Inflammation and Autoimmunity
Anna Luenemann et al.
MOLECULAR MEDICINE (2009)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells
Lars Andresen et al.
JOURNAL OF IMMUNOLOGY (2007)
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis
Cristina Cerboni et al.
BLOOD (2007)
CD56bright human NK cells differentiate into CD56dim cells:: Role of contact with peripheral fibroblasts
Antoni Chan et al.
JOURNAL OF IMMUNOLOGY (2007)
Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
M. Saraste et al.
NEUROLOGICAL SCIENCES (2007)
Inflammatory cell migration into the central nervous system: A few new twists on an old tale
Shumei Man et al.
BRAIN PATHOLOGY (2007)
Reciprocal regulation between natural killer cells and autoreactive T cells
Fu-Dong Shi et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Human natural killer cell development and biology
Sherif S. Farag et al.
BLOOD REVIEWS (2006)
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Cutting edge:: NKG2D is a costimulatory receptor for human naive CD8+ T cells
K Maasho et al.
JOURNAL OF IMMUNOLOGY (2005)
CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
KE Sloan et al.
BMC CANCER (2004)
IL-15Rα recycles and presents IL-15 in trans to neighboring cells
S Dubois et al.
IMMUNITY (2002)
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity
MT Kasaian et al.
IMMUNITY (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset
MA Cooper et al.
BLOOD (2001)
Adhesion to target cells is disrupted by the killer cell inhibitory receptor
DN Burshtyn et al.
CURRENT BIOLOGY (2000)
Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patients
P Perini et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Share Paper
